本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Sarepta Therapeutics

20.22
-0.5050-2.44%
成交量:74.22萬
成交額:1,501.66萬
市值:21.34億
市盈率:-15.36
高:20.78
開:20.68
低:19.88
收:20.72
52周最高:25.32
52周最低:14.68
股本:1.06億
流通股本:9,905.26萬
量比:0.63
換手率:0.75%
股息:- -
股息率:- -
每股收益(TTM):-1.3161
每股收益(LYR):-7.1300
淨資產收益率:-9.48%
總資產收益率:-1.13%
市淨率:1.40
市盈率(LYR):-2.84

資料載入中...

2024/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/28

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/09

重要事件披露

Form 8-K - Current report
2023/11/01

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/02

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/02

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/06/23

重要事件披露

Form 8-K - Current report
2023/06/23

重要事件披露

Form 8-K - Current report
2023/06/09

重要事件披露

Form 8-K - Current report
2023/05/02

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/03

重要事件披露

8-K - Current report
2023/02/28

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals